Sumitomo Pharma America, Inc.

This early-stage study is testing the safety and finding the right dose of an experimental oral drug called DSP-0390 for adults whose aggressive brain tumors (high-grade gliomas) have returned. The main goals are to see what side effects occur and to measure how the drug behaves …

This study aims to better understand how vision declines in adults with severe retinitis pigmentosa (RP), a rare genetic eye disease. Researchers will observe 12 participants over 12 months to see which vision tests work reliably for people with low vision and to measure how quic…